Gilead Sciences Inc buy melinda
Start price
31.08.17
/
50%
€74.64
Target price
27.12.17
€81.18
Performance (%)
-10.85%
End price
27.12.17
€65.60
Summary
This prediction ended on 27.12.17 with a price of €65.60. The prediction for Gilead Sciences Inc disappointed with a performance of -10.85%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Gilead Sciences Inc | -1.808% | -1.808% | 16.426% | 68.814% |
| iShares Core DAX® | -6,02 % | -4,60 % | 1,28 % | 48,46 % |
| iShares Nasdaq 100 | 0,51 % | 0,16 % | 14,40 % | 85,25 % |
| iShares Nikkei 225® | -7,16 % | -2,21 % | 27,89 % | 50,35 % |
| iShares S&P 500 | -0,26 % | -0,84 % | 10,25 % | 58,65 % |
Comments by melinda for this prediction
In the thread Gilead Sciences Inc diskutieren
genehmigt
Stribild
NDA # 203100 Cobicistat; Elvitegravir; Emtricitabin; Tenofovir Disoproxil Fumarat Tabletten; Oral-EXTRA 30 Gilead Sciences Inc Labeling Approved
(Vom Mitglied beendet)
Stopped prediction by melinda for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€78.80
19.04.20
19.04.20
€80.00
04.11.21
04.11.21
-26.85%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€67.97
27.03.18
27.03.18
€80.10
27.09.18
27.09.18
3.73%
27.09.18
27.09.18
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.42
05.03.18
05.03.18
€79.38
19.03.18
19.03.18
2.32%
19.03.18
19.03.18
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.45
10.05.16
10.05.16
€84.79
10.11.16
10.11.16
-8.50%
10.11.16
10.11.16
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€12.69
21.07.10
21.07.10
€22.50
22.12.10
22.12.10
9.55%
22.12.10
22.12.10